This is the authors' abstract. We don't add key points for this paper.
A major side effect of chemotherapy is hematoxicity. Gene transfer of drug resistance genes, such as methylguanine-DNA-methyltransferase (MGMT), to primitive hematopoietic progenitor cells has been examined as a possible solution for circumventing this problem. This study by Grund et al. examines the effect of alkylator chemotherapy treatment on the integration pattern of lentiviral self-inactivating (SIN) vector mediated delivery of MGMT in human peripheral blood progenitor cells. Hematotoxicity is a major and frequently dose-limiting side effect of chemotherapy. Retroviral methylguanine-DNA-methyltransferase (MGMT; EC 2.1.1.63) gene transfer to primitive hematopoietic progenitor cells (CD34+ cells) might allow the application of high-dose alkylator chemotherapy with almost mild to absent myelosuppression. Because gammaretroviral vector integration was found in association with malignant or increased proliferation, novel lentiviral vectors with self-inactivating (SIN) capacity might display a safer option for future gene transfer studies. We assessed the influence of chemoselection on integration patterns in 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-treated and untreated human CD34+ cells transduced with an SIN lentiviral vector carrying the MGMTP140K transgene, using ligation-mediated PCR (LM-PCR) and next-generation sequencing. In addition, for the first time, the local influence of the lentiviral provirus on the expression of hit and flanking genes in human CD34+ cells was analyzed at a clonal level. For each colony, the integration site was detected (LM-PCR) and analyzed (QuickMap), and the expression of hit and flanking genes was measured (quantitative RT-PCR). Analyses of both treated and untreated CD34+ cells revealed preferential integration into genes. Integration patterns in BCNU-treated cells showed mild, but not significant, differences compared with those found in untreated CD34+ cells. Most importantly, when analyzing the local influence of the provirus, we saw no significant deregulation of the integration-flanking genes. These findings demonstrate that SIN vector-mediated gene transfer might display a feasible and possibly safe option for MGMTP140K-mediated chemoprotection of CD34+ cells.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Grund et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: